265 related articles for article (PubMed ID: 26621337)
1. The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia.
Rouce RH; Shaim H; Sekine T; Weber G; Ballard B; Ku S; Barese C; Murali V; Wu MF; Liu H; Shpall EJ; Bollard CM; Rabin KR; Rezvani K
Leukemia; 2016 Apr; 30(4):800-11. PubMed ID: 26621337
[TBL] [Abstract][Full Text] [Related]
2. TGF-β regulated leukemia cell susceptibility against NK targeting through the down-regulation of the CD48 expression.
Huang CH; Liao YJ; Chiou TJ; Huang HT; Lin YH; Twu YC
Immunobiology; 2019 Sep; 224(5):649-658. PubMed ID: 31421859
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of NK cells in Mexican pediatric patients with acute lymphoblastic leukemia: Report from the Mexican Interinstitutional Group for the Identification of the Causes of Childhood Leukemia.
Valenzuela-Vazquez L; Núñez-Enríquez JC; Sánchez-Herrera J; Jiménez-Hernández E; Martín-Trejo JA; Espinoza-Hernández LE; Medina-Sanson A; Flores-Villegas LV; Peñaloza-González JG; Refugio Torres-Nava J; Espinosa-Elizondo RM; Amador-Sánchez R; Santillán-Juárez JD; Flores-Lujano J; Pérez-Saldívar ML; García-López LR; Castañeda-Echevarría A; Rodríguez-Leyva F; Rosas-Vargas H; Mata-Rocha M; Duarte-Rodríguez DA; Sepúlveda-Robles OA; Mancilla-Herrera I; Mejía-Aranguré JM; Cruz-Munoz ME
PLoS One; 2020; 15(1):e0227314. PubMed ID: 31951638
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway.
Xia Y; Zhang Q; Zhen Q; Zhao Y; Liu N; Li T; Hao Y; Zhang Y; Luo C; Wu X
Oncotarget; 2017 Jun; 8(23):37783-37795. PubMed ID: 28384121
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells derived from low risk acute lymphoblastic leukemia patients promote NK cell antitumor activity.
Entrena A; Varas A; Vázquez M; Melen GJ; Fernández-Sevilla LM; García-Castro J; Ramírez M; Zapata AG; Vicente Á
Cancer Lett; 2015 Jul; 363(2):156-65. PubMed ID: 25917077
[TBL] [Abstract][Full Text] [Related]
6. Activin-A attenuates several human natural killer cell functions.
Robson NC; Wei H; McAlpine T; Kirkpatrick N; Cebon J; Maraskovsky E
Blood; 2009 Apr; 113(14):3218-25. PubMed ID: 19141859
[TBL] [Abstract][Full Text] [Related]
7. Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma.
Zecca A; Barili V; Canetti D; Regina V; Olivani A; Carone C; Capizzuto V; Zerbato B; Trenti T; Dalla Valle R; Ferrari C; Cariani E; Missale G
Cancer Immunol Immunother; 2020 Aug; 69(8):1589-1603. PubMed ID: 32307580
[TBL] [Abstract][Full Text] [Related]
8. The transforming growth factor beta 1/SMAD signaling pathway involved in human chronic myeloid leukemia.
Su E; Han X; Jiang G
Tumori; 2010; 96(5):659-66. PubMed ID: 21302608
[TBL] [Abstract][Full Text] [Related]
9. Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy.
Yang B; Liu H; Shi W; Wang Z; Sun S; Zhang G; Hu Y; Liu T; Jiao S
Int Immunopharmacol; 2013 Oct; 17(2):198-204. PubMed ID: 23806302
[TBL] [Abstract][Full Text] [Related]
10. CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies.
Al Sayed MF; Ruckstuhl CA; Hilmenyuk T; Claus C; Bourquin JP; Bornhauser BC; Radpour R; Riether C; Ochsenbein AF
Blood; 2017 Jul; 130(3):297-309. PubMed ID: 28495792
[TBL] [Abstract][Full Text] [Related]
11. TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer.
Slattery K; Woods E; Zaiatz-Bittencourt V; Marks S; Chew S; Conroy M; Goggin C; MacEochagain C; Kennedy J; Lucas S; Finlay DK; Gardiner CM
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33568351
[TBL] [Abstract][Full Text] [Related]
12. Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.
Wilson EB; El-Jawhari JJ; Neilson AL; Hall GD; Melcher AA; Meade JL; Cook GP
PLoS One; 2011; 6(9):e22842. PubMed ID: 21909397
[TBL] [Abstract][Full Text] [Related]
13. CRTAM
Ramírez-Ramírez D; Padilla-Castañeda S; Galán-Enríquez CS; Vadillo E; Prieto-Chávez JL; Jiménez-Hernández E; Vilchis-Ordóñez A; Sandoval A; Balandrán JC; Pérez-Tapia SM; Ortiz-Navarrete V; Pelayo R
J Leukoc Biol; 2019 May; 105(5):999-1013. PubMed ID: 30791148
[TBL] [Abstract][Full Text] [Related]
14. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity.
Mamessier E; Sylvain A; Thibult ML; Houvenaeghel G; Jacquemier J; Castellano R; Gonçalves A; André P; Romagné F; Thibault G; Viens P; Birnbaum D; Bertucci F; Moretta A; Olive D
J Clin Invest; 2011 Sep; 121(9):3609-22. PubMed ID: 21841316
[TBL] [Abstract][Full Text] [Related]
15. An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression.
Fujii R; Jochems C; Tritsch SR; Wong HC; Schlom J; Hodge JW
Cancer Immunol Immunother; 2018 Apr; 67(4):675-689. PubMed ID: 29392336
[TBL] [Abstract][Full Text] [Related]
16. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia.
Quintarelli C; Sivori S; Caruso S; Carlomagno S; Falco M; Boffa I; Orlando D; Guercio M; Abbaszadeh Z; Sinibaldi M; Di Cecca S; Camera A; Cembrola B; Pitisci A; Andreani M; Vinti L; Gattari S; Del Bufalo F; Algeri M; Li Pira G; Moseley A; De Angelis B; Moretta L; Locatelli F
Leukemia; 2020 Apr; 34(4):1102-1115. PubMed ID: 31745215
[TBL] [Abstract][Full Text] [Related]
18. Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia.
Stringaris K; Sekine T; Khoder A; Alsuliman A; Razzaghi B; Sargeant R; Pavlu J; Brisley G; de Lavallade H; Sarvaria A; Marin D; Mielke S; Apperley JF; Shpall EJ; Barrett AJ; Rezvani K
Haematologica; 2014 May; 99(5):836-47. PubMed ID: 24488563
[TBL] [Abstract][Full Text] [Related]
19. Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells.
Torelli GF; Peragine N; Raponi S; Pagliara D; De Propris MS; Vitale A; Bertaina A; Barberi W; Moretta L; Basso G; Santoni A; Guarini A; Locatelli F; Foà R
Haematologica; 2014 Jul; 99(7):1248-54. PubMed ID: 24658822
[TBL] [Abstract][Full Text] [Related]
20. The crosstalk between endometrial stromal cells and macrophages impairs cytotoxicity of NK cells in endometriosis by secreting IL-10 and TGF-β.
Yang HL; Zhou WJ; Chang KK; Mei J; Huang LQ; Wang MY; Meng Y; Ha SY; Li DJ; Li MQ
Reproduction; 2017 Dec; 154(6):815-825. PubMed ID: 28971893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
